<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		
		<title>Addex Pharmaceuticals: News</title>
		<link>http://www.addexpharma.com/</link>
		<description>Latest News</description>
		<language>en</language>
		<generator>TYPO3 - get.content.right</generator>
		<docs>http://blogs.law.harvard.edu/tech/rss</docs>
		
		
		
		<lastBuildDate>Sun, 27 Nov 2011 22:12:00 +0100</lastBuildDate>
		
		
		<item>
			<title>Addex Scientists Discover Glucagon-like-peptide-1 (GLP-1) Induced Interaction Between GLP-1 and Gastric Inhibitory Peptide (GIP) Receptors </title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-scientists-discover-glucagon-like-peptide-1-glp-1-induced-interaction-between-glp-1-and-gast/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-scientists-discover-glucagon-like-peptide-1-glp-1-induced-interaction-between-glp-1-and-gast/</guid>
			<description>The Addex Allosteric Modulator Platform Enabled Breakthrough Discovery, Advancing the Understanding of GLP-1 Mediated GPCR Signaling

Geneva, Switzerland, 28 November 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pion...</description>
			<category>2011</category>
			
			
			<pubDate>Sun, 27 Nov 2011 22:12:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>Addex Presents Data on Allosteric Modulators of GPCRs at the Discovery on Target Conference</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-presents-data-on-allosteric-modulators-of-gpcrs-at-the-discovery-on-target-conference/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-presents-data-on-allosteric-modulators-of-gpcrs-at-the-discovery-on-target-conference/</guid>
			<description>3 Presentations on Preclinical Programs for Oral GLP-1R, mGluR4 &amp; GABA-BR Positive Allosteric Modulators</description>
			<category>2011</category>
			
			
			<pubDate>Tue, 01 Nov 2011 23:29:00 +0100</pubDate>
			
		</item>
		
		<item>
			<title>Addex to Present at the BIO Investor Forum in San Francisco</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-at-the-bio-investor-forum-in-san-francisco/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-at-the-bio-investor-forum-in-san-francisco/</guid>
			<description>English (pdf)
 Geneva, Switzerland, October 24, 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Dr. Bharatt Chowrira, CEO o...</description>
			<category>2011</category>
			
			
			<pubDate>Mon, 24 Oct 2011 10:49:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex to Present in NYC at the Newsmakers in the Biotech Industry conference hosted by BioCentury and Thomson Reuters</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-in-nyc-at-the-newsmakers-in-the-biotech-industry-conference-hosted-by-biocentury-an/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-in-nyc-at-the-newsmakers-in-the-biotech-industry-conference-hosted-by-biocentury-an/</guid>
			<description>English (pdf)
  Geneva, Switzerland, October 19, 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Dr. Bharatt Chowrira, CEO ...</description>
			<category>2011</category>
			
			
			<pubDate>Wed, 19 Oct 2011 18:00:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex to Present Progress on Multiple Allosteric Modulator Programs for Neurodegenerative and other Neurological Disorders </title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-progress-on-multiple-allosteric-modulator-programs-for-neurodegenerative-and-other/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-progress-on-multiple-allosteric-modulator-programs-for-neurodegenerative-and-other/</guid>
			<description>English (pdf)
Six Presentations at the 7th International Meeting on Metabotropic Glutamate Receptors
Geneva, Switzerland, October 3, 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based...</description>
			<category>2011</category>
			
			
			<pubDate>Mon, 03 Oct 2011 15:41:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex to Present at the Jefferies 2011 Global Healthcare Conference in London</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-at-the-jefferies-2011-global-healthcare-conference-in-london/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-to-present-at-the-jefferies-2011-global-healthcare-conference-in-london/</guid>
			<description>
Geneva, Switzerland, September 26, 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that Dr. Bharatt Chowrira, CEO of Addex, will pro...</description>
			<category>2011</category>
			
			
			<pubDate>Sun, 25 Sep 2011 19:10:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex Regains Rights to Parkinson’s Drug Candidates from Merck</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-regains-rights-to-parkinsons-drug-candidates-from-merck/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-regains-rights-to-parkinsons-drug-candidates-from-merck/</guid>
			<description>English (pdf)
   Geneva, Switzerland, 2 September 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it will regain all r...</description>
			<category>2011</category>
			
			
			<pubDate>Fri, 02 Sep 2011 14:15:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex Pharmaceuticals Appoints Dr Bharatt Chowrira as CEO</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-appoints-dr-bharatt-chowrira-as-ceo/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-appoints-dr-bharatt-chowrira-as-ceo/</guid>
			<description>Français (pdf)English (pdf)Geneva, Switzerland, 15 August 2011 – Addex Pharmaceuticals (SIX:ADXN), a leading biopharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today the appointment of Dr Bharat...</description>
			<category>2011</category>
			
			
			<pubDate>Mon, 15 Aug 2011 14:17:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex Pharmaceuticals Announces Board Changes</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-announces-board-changes/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-announces-board-changes/</guid>
			<description>Vincent Lawton appointed to Vice-Chairman</description>
			<category>2011</category>
			
			
			<pubDate>Thu, 11 Aug 2011 22:52:00 +0200</pubDate>
			
		</item>
		
		<item>
			<title>Addex Pharmaceuticals First Half 2011 Financial Results</title>
			<link>http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-first-half-2011-financial-results/</link>
			<guid>http://www.addexpharma.com/press-releases/press-release-details/article/addex-pharmaceuticals-first-half-2011-financial-results/</guid>
			<description>English (pdf)Français (pdf)                                  Deutsch (pdf) 
WebcastCondensed Consolidated Interim Financial Statements
Geneva, Switzerlan...</description>
			<category>2011</category>
			
			
			<pubDate>Wed, 27 Jul 2011 20:16:00 +0200</pubDate>
			
		</item>
		
	</channel>
</rss>
